Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial

BMJ Open

Volumn 6, Issue 8, 2016, Pages

  Stokes, E A ^a   Wordsworth, S ^a   Bargo, D ^a,b   Pike, K ^c   Rogers, C A ^c   Brierley, R C M ^c   Angelini, G D ^c   Murphy, G J ^d   Reeves, B C ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

blood transfusion; cost effectiveness

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; FRESH FROZEN PLASMA; HEMOGLOBIN; TRANEXAMIC ACID;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATE; EMERGENCY CARE; ERYTHROCYTE TRANSFUSION; FEMALE; FORWARD HEART FAILURE; HEALTH CARE COST; HEART INFARCTION; HEART SURGERY; HEART VALVE SURGERY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MULTICENTER STUDY; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; THORAX DRAINAGE; THROMBOCYTE TRANSFUSION; UNITED KINGDOM; ANEMIA; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; ERYTHROCYTE; HOSPITAL COST; METABOLISM; NATIONAL HEALTH SERVICE; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR;

AGED; ANEMIA; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOGLOBINS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE; UNITED KINGDOM;

EID: 84982859352     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011311     Document Type: Article

References (36)

1. Habib RH, Zacharias A, Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005;33:1749-56.
2. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52.
3. Karkouti K, Wijeysundera DN, Beattie WS, et al. Risk associated with preoperative anemia in cardiac surgery: A multicenter cohort study. Circulation 2008;117:478-84.
4. Bennett-Guerrero E, Zhao Y, OBrien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010;304:1568-75.
5. Murphy MF, Murphy GJ, Gill R, et al. National Comparative Audit of Blood Transfusion: 2011 Audit of Blood Transfusion in Adult Cardiac Surgery. 2013. http://hospital.blood.co.uk/media/26859/nca-2011-use-of-blood-in-Adult-cardiac-surgery-report.pdf (accessed 30 Jul 2015).
6. Wells AW, Llewelyn CA, Casbard A, et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by The National Blood Service. Transfus Med 2009;19:315-28.
7. Brierley RCM, Pike K, Miles A, et al. A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery: study protocol. Transfus Apher Sci 2014;50:451-61.
8. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest 1995;108:767-71.
9. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998;88:327-33.
10. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015;372: 997-1008.
11. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. 2013. https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-To-The-methods-oftechnology-Appraisal-2013-pdf (accessed 30 Jul 2015).
12. Department of Health. National Schedule of Reference Costs 201213. London: Department of Health, 2013.
13. NHS Blood and Transplant. NHS Blood and Transplant Price List 20122013. 2012. http://hospital.blood.co.uk/products/ (accessed 28 Sep 2012).
14. Curtis L. Unit costs of health and social care 2013. Canterbury: Personal Social Services Research Unit, University of Kent, 2013.
15. Department of Health Commercial Medicines Unit. Electronic Marketing Information Tool (eMIT). Drugs and Pharmaceutical Electronic Market Information (eMit). http://cmu.dh.gov.uk/electronic-market-information-Tool-emit/ (accessed 10 Feb 2014).
16. Joint Formulary Committee. British national formulary. No. 66. London: BMJ Group and Pharmaceutical Press, 2013.
17. Dolan P, Gudex C, Kind P, et al. A social tariff for euroqol: results from a UK general population survey. University of York, 1995.
18. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
19. Rubin DB. Multiple Imputation for non-response in surveys. New York: John Wiley, 1987.
20. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: The importance of controlling for baseline utility. Health Econ 2005;14:487-96.
21. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
22. Briggs A, Clark T, Wolstenholme J, et al. Missingpresumed at random: cost-Analysis of incomplete data. Health Econ 2003;12:377-92.
23. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753-65.
24. Shander A, Ozawa S, Hofmann A. Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital. Vox Sang 2016;111:55-61.
25. Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012;52:1983-8.
26. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012;(4):CD002042.
27. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
28. Shehata N, Burns LA, Nathan H, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012;52:91-9.
29. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013;165:964-71.e1.
30. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
31. Walsh TS, Boyd JA, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: A randomized pilot trial. Crit Care Med 2013;41:2354-63.
32. Holst LB, Petersen MW, Haase N, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-Analysis and trial sequential analysis. BMJ 2015;350:h1354.
33. Docherty AB, ODonnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-Analysis. BMJ 2016;352:i1351.
34. Patel NN, Avlonitis VS, Jones HE, et al. Indications for red blood cell transfusion in cardiac surgery: A systematic review and meta-Analysis. Lancet Haematol 2015;2:e543-53.
35. The Society for Cardiothoracic Surgery in Great Britain & Ireland. Blue Book Online. 2013. http://bluebook.scts.org
36. NHS Blood and Transplant. 2015 Audit of Patient Blood Management in adults undergoing elective, scheduled surgery. 2016. http://hospital.blood.co.uk/audits/national-comparative-Audit/(accessed 20 Apr 2016).